Cannabis patch startup pulls off a $42M IPO to fund drugs for epilepsy, pain

Damian Garde Pennsylvania drugmaker Zynerba Pharmaceuticals is making its way to Wall Street with some cannabis-derived treatments for central nervous system disorders, raising $ 42 ...

GW hits the FDA fast track with its cannabis-based epilepsy drug

Damian Garde The FDA has applied its fast-track designation to GW Pharmaceuticals' Epidiolex, a cannabinoid treatment for a rare form of epilepsy. FierceBiotech News

Eisai: Zonegran Well-Tolerated by Elderly Patients With Partial Epilepsy

barbara.lempert Data Shows Zonegran® (Zonisamide) is Well-Tolerated by Elderly Patients With Partial Epilepsy HATFIELD, England, July 16, 2013 /PRNewswire/ — Pooled-analysis ...

Eisai Halts Sale Of Epilepsy Drug In Germany Over Price Row

esilverman Three months ago, Eisai executives sputtered that they were “appalled” at the German Federal Joint Committee, which is the national reimbursement agency, for ...

E Keppra Tablet Approved in Japan for Pediatric Epilepsy

barbara.lempert Antiepileptic Drug E Keppra® Tablet Approved in Japan for Pediatric Epilepsy (Partial-Onset Seizures)Epilepsy occurs most frequently in infants and elderly, and it ...

Sanofi embarks on doc-training in Morocco to boost diabetes, epilepsy care

Tracy Staton In established markets, Big Pharma targets doctors to boost sales. In emerging markets, drugmakers train them. Directly. Several of the globe's biggest pharma companies ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS